CLINICAL EVALUATION OF KW-1062 IN VARIOUS LUNG INFECTIONS

Abstract

Eight patients with various intractable lung infections (9 cases) received daily 120 mg of KW-1062 divided into two or three doses by intramuscular route for 5 to 12 days. The effect was excellent in 1 case, good in 2, fair in 3 and poor in 3. The rate of effectiveness was 66. 7%. There were no changes attributable to KW-1062 in blood picture or in liver or renal function. Side effects such as impairment of the 8 th nerve were not noted.